ITGR Integer Holdings Corp
Q3 2025 10-Q
Filed: Oct 23, 2025Period ending Sep 26, 2025
Health Care
Electromedical & Electrotherapeutic ApparatusSEC EDGAR Integer Holdings Corp (ITGR) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 23, 2025 for the fiscal period ending Sep 26, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Risk Factors
- • New convertible notes issuance risk triggered by $1.0B 2030 Convertible Senior Notes at 1.875% due 2030, with $976.1M net proceeds and induced conversion expense $46.7M Q1 2025
- • Financial risk materially updated: partial repayment of revolving credit and TLA Facility with proceeds from note issuance, impacting liquidity and debt structure
Quarterly Financial SummaryXBRL
Revenue
$468M
▲ +12.4% YoY▼ -1.8% QoQ
Net Income
$40M
▲ +12.0% YoY▲ +7.2% QoQ
Gross Margin
27.0%
▼ -18bp YoY▼ -13bp QoQ
Operating Margin
12.1%
▼ -157bp YoY▼ -39bp QoQ
Net Margin
8.5%
▼ -3bp YoY▲ +72bp QoQ
ROE
2.3%
Total Assets
$3.4B
EPS (Diluted)
$1.11
▲ +12.1% YoY▲ +3.7% QoQ
Operating Cash Flow
$66M
▼ -8.3% YoY▲ +49.5% QoQ
Source: XBRL data from Integer Holdings Corp Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Integer Holdings Corp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.